“After progress in a second round of tests using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval in China for a third and final phase, which it hopes to start in the autumn. 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury. The treatment involves injecting umbilical cord blood mononuclear cells into patients’ damaged spines to help regenerate nerves, while lithium is used to promote the growth of the nerve fibres.”
Related posts:
NYC not liable for processing fake deed allowing theft of woman’s home
First Chinese military officials charged with stealing US companies' data
Why Milk Prices Could More Than Double After January 1
'Sovereign citizen' pays fines with 70,000 pennies
Gold Runs Out In Lisbon As Price Drop Compounds Money Misery
Tradehill Bitcoin Accounts Moving to Internet Archive Credit Union
London Seeks New Spenders as Russians Skip $719 Champagne
Trooper who ticketed cop for speeding sues cops for harassment
‘Citizen Drone Warfare’: Hobbyist explores a frightening scenario
Do bitcoins belong in your retirement portfolio?
NSA shares raw intelligence including Americans' data with Israel
CIA operators were denied request for help during Benghazi attack
Lucerne orchestra axes concert with Depardieu over tax shopping
Cash machines robbed with infected USB sticks
SF tech bus program could be stalled by environmental appeals